Influence of nitrovasodilators and endothelin-1 on rheology of human blood in vitro

British Journal of Pharmacology

Volumn 128, Issue 3, 1999, Pages 744-750

  Walter, Roland ^a   Mark, Michael ^a   Gaudenz, Roman ^a   Harris, Llinos G ^b   Reinhart, Walter H ^a  

^a KANTONSSPITAL GRAUBÜNDEN   (Switzerland)

^b AO RESEARCH INSTITUTE   (Switzerland)

Author keywords

Endothelin; Erythrocyte; Methaemoglobin; Nitric oxide; Nitrovasodilator; Rheology; Viscosity

Indexed keywords

CYANIDE; ENDOTHELIN 1; GLYCERYL TRINITRATE; METHEMOGLOBIN; MOLSIDOMINE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; VASODILATOR AGENT;

ARTICLE; BLOOD RHEOLOGY; BLOOD VESSEL TONE; BLOOD VISCOSITY; CONTROLLED STUDY; ECHINOCYTE; ERYTHROCYTE SHAPE; HEMATOCRIT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SHEAR RATE; SHEAR STRESS;

ADULT; ANTICOAGULANTS; BLOOD VISCOSITY; ENDOTHELIN-1; HEPARIN; HUMANS; MICROSCOPY, ELECTRON; NITRIC OXIDE DONORS; NITROGLYCERIN; VASODILATOR AGENTS;

EID: 0032700575     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702817     Document Type: Article

References (44)

1. ABRAMS, J. (1996). Beneficial actions of nitrates in cardiovascular disease. Am. J. Cardiol., 77, 31C-37C.
2. AGRAWAL, D., GUPTA, G.S., SHUKLA, J.S., DUTTA, K.K. & RAY, P.K. (1990). Effect of methyl isocyanate (MIC) on rat erythrocytes. Arch. Toxicol., 64, 332-335.
3. ARCHER, S. (1993). Measurement of nitric oxide in biological models. FASEB J., 7, 349-360.
4. BENNETT, B.M., KOBUS, S.M., BRIEN, J.F., NAKATSU, K. & MARKS, G.S. (1986). Requirement for reduced, unliganded hemoprotein for the hemoglobin-and myoglobin-mediated biotransformation of glyceryl trinitrate. J. Pharmacol. Exp. Ther., 237, 629-635.
5. BENNETT, B.M., MCDONALD, B.J., NIGAM, R, & SIMON, W.C. (1994). Biotransformation of organic nitrates and vascular smooth muscle cell function. Trends Pharmacol. Sci., 15, 245-249.
6. BESSIS, M. (1972). Red cell shapes: an illustrated classification and its rationales. Nouv. Rev. Fr. Hematol., 12, 721-746.
7. CARAMELO, C., RIESCO, A., OUTEIRINO, J., MILLAS, I., BLUM, G., MONZU, B., CASADO, V., SANCHEZ, L., MOSQUERA, J.R., CASADO, S. & LOPEZ FARRE, A. (1994). Effects of nitric oxide on red blood cells: changes in crythrocyte resistance to hypotonic hemolysis and potassium efflux by experimental maneuvers that decrease nitric oxide. Biochem. Biophys. Res. Commun., 199, 447-454.
8. CHIEN, S. (1975). Biophysical behaviour or red cells in suspension. In: MacN. Surgenor, D ed. The Red Blood Cell. Academic Press, New York. pp. 1031-1133.
9. COOKE, J.P. & DZAU, V.J. (1997). Nitric oxide synthase: role in the genesis of vascular disease. Annu. Rev. Med., 48, 489-509.
10. FEELISCH, M., OSTROWSKI, J, & NOACK, E. (1989). On the mechanism of NO release from sydnonimines. J. Cardiovasc. Pharmacol., 14 (Suppl 11): S13-S22.
11. FERRELL, J.E. & HUESTIS, W.H. (1984). Phosphoinositide metabolism and the morphology of human erythrocyte. J. Cell Biol., 98, 1992-1998.
12. GIUGLIANO, D., MARFELLA, R., ACAMPORA, R., GIUNTA, R., COPPOLA, L. & D'ONOFRIO, F. (1998). Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension. Diabetes Care, 21, 631-636.
13. GIUGLIANO, D., MARFELLA, R., VERRAZZO, G., ACAMPORA, R., COPPOLA, L., COZZOLINO, D. & D'ONOFRIO, F. (1997). The vascular elfects of L-Arginine in humans. The role of endogenous insulin. J. Clin. Invest., 99, 433-438.
14. GIUGLIANO, D., MARFELLA, R., VERRAZZO, G., ACAMPORA, R., DONZELLA, C., QUATRARO, A., COPPOLA, I., & D'ONOFRIO, F. (1995). Abnormal rheologic effects of glyceryl trinitrate in patients with non-insulin-dependent diabetes mellitus and reversal by antioxidants. Ann. Intern Med., 123, 338-343.
15. HARRISON, D.G. & BATES, J.N. (1993). The nitrovasodilators. New ideas about old drugs. Circulation, 87, 1461-1467.
16. HOGMAN, M., FROSTELL, C., ARNBERG, H., SANDHAGEN, B. & HEDENSTIERNA, G. (1994). Prolonged bleeding time during nitric oxide inhalation in the rabbit. Acta Physiol. Scand., 151, 125-129.
17. JOZWIK, M., JOZWIK, M., JOZWIK, M., SZCZYPKA, M., GAJEWSKA, J. & LASKOWSKA-KLITA, T. (1997). Antioxidant defence of red blood cells and plasma in stored human blood. Clin. Chim. Acta, 267, 129-142.
18. KORBUT, R. & GRYGLEWSKI, R.J. (1993). Nitric oxide from polymorphonuclear leukocytes modulates red blood cell deformability in vitro. Eur. J. Pharmacol., 234, 17-22.
19. KOWALUK, E.A. & FUNG, H.L. (1990). Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols. J. Pharmacol. Exp. Ther., 255, 1256-1264.
20. LUSCHER, T.F. (1991). Endothelium-derived nitric oxide: the endogenous nitrovasodilator in the human cardiovascular system. Eur. Heart J., 12 (Suppl E): 2-11.
21. MAEDA, N., IMAIZUMI, K., KON, K. & SHIGA, T. (1987). A kinetic study on functional impairment of nitric oxide-exposed rat erythrocytes. Environ. Health Perspect., 73, 171-177.
22. MALEK, A.M. & IZUMO, S. (1995). Control of endothelial cell gene expression by flow. J. Biomech., 28, 1515-1528.
23. MARLETTA, M.A. (1994). Nitric oxide synthase: aspects concerning structure and catalysis. Cell, 78, 927-930.
24. MCHUGH, J. & CHEEK, D.J. (1998). Nitric oxide and regulation of vascular tone: pharmacological and physiological considerations. Am. J. Crit. Care, 7, 131-140.
25. MEINERTZ, T., BRANDSTAETTER, A., TRENK, D., JAEHNCHEN, E. & OSTROWSKI, J. (19S6). Relationship between pharmacokinetics and pharmacodynamics of molsidomine and its metabolites in man. In: Bing, R.J. & Strauch, M. (eds). Ischemic Heart Disease and Heart Failure. Urban & Schwarzenberg pp. 24-27.
26. MOREAU, R. & LEBREC, D. (1990). Nitrovasodilators and portal hypertension. J. Hepatol., 10, 263-267.
27. NATHAN, C. & XIE, Q.W. (1994). Nitric oxide synthase: roles, tolls, and controls. Cell, 78, 715-718.
28. NOONAN, P.K. & BENET, L.Z. (1985). Incomplete and delayed bioavailability of sublingual nitroglycerin. Am. J. Cardiol., 55, 184-187.
29. OONISHl, T., SAKASHITA, K., SUEMATSU, N. & UYESAKA, N. (1997). Endothelin-1 improves impaired red cell filterability under mechanical stress. Blood, 90 (10 Suppl 1): 7b (Abstract 2713).
30. OONISHI, T., SAKASHITA, K., SUEMATSU, N. & UYESAKA, N. (1998). Endothelin-1 improves the impaired filterability of red blood cells through activation of protein kinase C. Blood, 92 (10 Suppl 1): 6a (Abstract 13).
31. REINHART, W.H. & CHIEN, S. (1986). Red cell rheology in stomatocyte-echinocyte transformation: roles of cell geometry and cell shape. Blood, 67, 1110-1118.
32. RICHARDS, R.G. & AP GWYNN, I. (1995). Backscattered electron imaging of the undersurface of resin-embedded cells by field-emission scanning electron microscopy. J. Microsc., 177, 43-52.
33. RIMAR, S. & GILLIS, C.N. (1993). Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation, 88, 2884-2887.
34. RIVERA, A. & BRUGNARA, C. (1998). Normal and sickle erythrocytes express an endothelin-1 receptor, which is functionally coupled to the gardo's channel: a new potential pathway for red blood cell dehydration. Blood, 92 (10 Suppl 1): 13a (Abstract 42).
35. ROBERTS JR., J.D., FINEMAN, J.R., MORIN 3RD, F.C., SHAUL, P.W., RIMAR, S., SCHREIBER, M.D., POLIN, R.A., ZWASS, M.S., ZAYEK, M.M., GROSS, I., HEYMANN, M.A. & ZAPOL, W.M. (1997). Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N. Engl. J. Med., 336, 605-610.
36. ROSENDORFF, C. (1997). Endothelin, vascular hypertrophy, and hypertension. Cardiovasc. Drugs Ther., 10, 795-802.
37. ROSENKRANZ, H., WINKELMANN, B.R. & PARNHAM, M.J. (1996). Clinical pharmacokinetics of molsidomine. Clin. Pharmacokinet., 30, 372-384.
38. SHEETZ, M.P. & SINGER, S.J. (1976). Equilibrium and kinetic effects of drugs on the shape of human erythrocytes. J. Cell Biol., 70, 247-251.
39. VANHOUTTE, P.M. & MOMBOULI, J.-V. (1996). Vascular endothelium: vasoactive mediators. Prog. Cadiovasc. Dis., 39, 229-238.
40. VESEY, C.J., SWEENEY, B. & COLE, P.V. (1990). Decay of nitroprusside. II: In vivo. Br. J. Anaesth., 64, 704-709.
41. WEBER, A.A., NEUHAUS, T., SEUL, C., DUSING, R., SCHROR, K., SACHINIDIS, A, & VETTER, H. (1996). Biotransformation of glyceryl trinitrate by blood platelets as compared to vascular smooth muscle cells. Eur. J. Pharmacol., 309, 209-213.
42. WENNMALM, A., BENTHIN, G. & PETERSSON, A.S. (1992). Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin. Br. J. Pharmacol., 106, 507-508.
43. ZIEGLER, T., BOUZOURENE, K., HARRISON, V.J., BRUNNER, H.R. & HAYOZ, D. (1998). Influence of oscillatory and unidirectional flow environments on the expression of endothelin and nitric oxide synthase in cultured endothelial cells. Arterioscler. Thromb. Vasc. Biol., 18, 686-692.
44. ZULSTRA, W.G. & BUURSMA, A. (1993). Rapid multicomponent analysis of hemoglobin derivatives for controlled antidotal use of methemoglobin-forming agents in cyanide poisoning. Clin. Chem., 39, 1685-1689.